logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Powell, Sarah Rhiannon
    Medical Advisor Pharmaceutical Indu born in November 1966
    Individual (2 offsprings)
    Officer
    2016-03-07 ~ dissolved
    OF - Director → CIF 0
    Mrs Sarah Rhiannon Powell
    Born in November 1966
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

SRP PHARMA CONSULTING LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Property, Plant & Equipment
19,674 GBP2020-03-31
Debtors
2,803 GBP2021-02-24
39,922 GBP2020-03-31
Cash at bank and in hand
312,714 GBP2021-02-24
288,682 GBP2020-03-31
Current Assets
315,517 GBP2021-02-24
328,604 GBP2020-03-31
Creditors
Current
19,357 GBP2021-02-24
66,628 GBP2020-03-31
Net Current Assets/Liabilities
296,160 GBP2021-02-24
261,976 GBP2020-03-31
Total Assets Less Current Liabilities
296,160 GBP2021-02-24
281,650 GBP2020-03-31
Creditors
Non-current
13,733 GBP2020-03-31
Net Assets/Liabilities
296,160 GBP2021-02-24
267,917 GBP2020-03-31
Equity
Called up share capital
130 GBP2021-02-24
130 GBP2020-03-31
Retained earnings (accumulated losses)
296,030 GBP2021-02-24
267,787 GBP2020-03-31
Equity
296,160 GBP2021-02-24
267,917 GBP2020-03-31
Average Number of Employees
12020-04-01 ~ 2021-02-24
12019-04-01 ~ 2020-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
24,717 GBP2020-03-31
Property, Plant & Equipment - Disposals
Plant and equipment
-24,717 GBP2020-04-01 ~ 2021-02-24
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
5,043 GBP2020-03-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Plant and equipment
-5,043 GBP2020-04-01 ~ 2021-02-24
Property, Plant & Equipment
Plant and equipment
19,674 GBP2020-03-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
6,001 GBP2020-03-31
Other Debtors
Current, Amounts falling due within one year
2,803 GBP2021-02-24
33,921 GBP2020-03-31
Debtors
Current, Amounts falling due within one year
2,803 GBP2021-02-24
39,922 GBP2020-03-31
Other Taxation & Social Security Payable
Current
18,112 GBP2021-02-24
54,357 GBP2020-03-31
Other Creditors
Current
1,245 GBP2021-02-24
12,271 GBP2020-03-31
Non-current
13,733 GBP2020-03-31

  • SRP PHARMA CONSULTING LTD
    Info
    Registered number 10045890
    3 Field Court, Gray's Inn, London WC1R 5EF
    PRIVATE LIMITED COMPANY incorporated on 2016-03-07 and dissolved on 2022-08-19 (6 years 5 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.